Paul Cox | Investor Relations |
Jeff Jonas | Chief Executive Officer |
Steve Kanes | Chief Medical Officer |
Kimi Iguchi | Chief Financial Officer |
Mike Cloonan | Chief Business Officer |
Jim Doherty | Chief Research Officer |
Tazeen Ahmad | Bank of America |
Neil Carnahan | Stifel |
Paul Matteis | Leerink |
Brian Abrahams | RBC Capital Markets |
Danielle Brill | Needham |
Tim Lugo | William Blair |
Gary Nachman | BMO Capital Markets |
John Newman | Canaccord |
Cory Kasimov | JP Morgan |
Ritu Baral | Cowen & Company |
Salveen Richter | Goldman Sachs |
Good morning, and welcome to Sage Therapeutics Fourth Quarter and Full Year 2017 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com. This call is a property of Sage Therapeutics and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded. I would now like to introduce Paul Cox, Investor Relations at Sage.